Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study
about
Addressing the current bottlenecks of metabolomics: Isotopic Ratio Outlier Analysis™, an isotopic-labeling technique for accurate biochemical profilingMeasurements of Gluconeogenesis and Glycogenolysis: A Methodological ReviewAdaptive reciprocity of lipid and glucose metabolism in human short-term starvationGene expression profile change and associated physiological and pathological effects in mouse liver induced by fasting and refeedingOrg 214007-0: a novel non-steroidal selective glucocorticoid receptor modulator with full anti-inflammatory properties and improved therapeutic indexDiscovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo.Acetaminophen glucuronide and plasma glucose report identical estimates of gluconeogenesis and glycogenolysis for healthy and prediabetic subjects using the deuterated water methodQuantifying the contribution of gluconeogenesis to glucose production in fasted human subjects using stable isotopes.Noninvasive measurement of murine hepatic acetyl-CoA ¹³C-enrichment following overnight feeding with ¹³C-enriched fructose and glucose.An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans.Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus.Mass spectrometry-based metabolomics.Additional evidence that transaldolase exchange, isotope discrimination during the triose-isomerase reaction, or both occur in humans: effects of type 2 diabetes.The Rudolf Schoenheimer Centenary Lecture. Isotopes in nutrition research.Limitations in the use of [U-13C6]glucose to estimate gluconeogenesis.Transaldolase exchange and its effects on measurements of gluconeogenesis in humans.Pituitary adenylate cyclase-activating polypeptide stimulates glucose production via the hepatic sympathetic innervation in rats.Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolismMethods for measuring glycogen cycling.Liver metabolite concentrations measured with 1H MR spectroscopy.Glycemic Allostasis during Mental Activities on Fasting in Non-alcohol Users and Alcohol Users with Different Durations of Abstinence.High protein diet maintains glucose production during exercise-induced energy deficit: a controlled trial.Protein quantity and quality at levels above the RDA improves adult weight loss.Glycogen branches out: new perspectives on the role of glycogen metabolism in the integration of metabolic pathways.Interaction between the central and peripheral effects of insulin in controlling hepatic glucose metabolism in the conscious dog.Dietary proteins contribute little to glucose production, even under optimal gluconeogenic conditions in healthy humans.Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.Deleted in breast cancer 1 (DBC1) protein regulates hepatic gluconeogenesis.Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD.Differential effects of pharmacological liver X receptor activation on hepatic and peripheral insulin sensitivity in lean and ob/ob mice.Hepatocytes contribute to residual glucose production in a mouse model for glycogen storage disease type Ia.Gluconeogenesis is associated with high rates of tricarboxylic acid and pyruvate cycling in fasting northern elephant seals.Glucose metabolism during lactation in a fasting animal, the northern elephant seal.An Oral Load of [13C3]Glycerol and Blood NMR Analysis Detect Fatty Acid Esterification, Pentose Phosphate Pathway, and Glycerol Metabolism through the Tricarboxylic Acid Cycle in Human Liver.Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women.The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.Fluxome analysis using GC-MS.Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.
P2860
Q24606161-2A1E90E5-9CCD-4D1A-A4E8-3F53C130FF1BQ26776006-55BE2634-E6AD-4F29-9A18-55057E9521C2Q26995512-7907B6FB-7C3D-4FC0-AE02-1BE7D1B49AE8Q28477889-F4531FE8-6F87-4EF6-92FB-D25A9667F5F7Q28485149-45C8D815-A13F-486B-A37D-F8208ECC0791Q30454428-2DDEDD92-FCD0-4CBE-A261-A699F164F86EQ30571338-55A15B63-77BF-49DC-975E-C94AEADE6586Q30596447-EB6C76EF-212F-4CA5-8620-618B60A37430Q30654400-449AB08C-BDEF-4930-8866-0E7FD6AE1B9FQ30660470-3A233C84-A51C-4618-B384-56591BDA1597Q31919769-839ED725-2E73-499F-A758-87D7E36CD095Q32066328-9007D5FA-7C8B-48DC-A2CC-D492B84611A2Q33254576-8CBEA92A-0EF1-4ED4-A680-421A99D9F661Q33430216-46DC3D4D-A6BF-42D6-B627-64B90A3C8D09Q33644430-756ECAD0-E5EC-41AA-B521-307C21322513Q33731949-3753C639-E318-4060-9CBE-086044FC8D88Q33742982-9184379D-4E71-4FE0-B3E0-91A008C4E1EEQ33930193-3ACC0BDC-2389-487F-B76B-D6683CF23DBAQ34325481-9254CF33-CBDA-4CC1-A4B8-4B12BBB6AD26Q34334102-DFBE1000-0BE4-4479-9874-ECF702AC3141Q34379180-6F558995-A2E7-442E-8F52-8AA6431BE5F5Q34418289-59508A6B-5B82-4B79-8B35-222DE2428416Q34999791-2E4BF044-7F52-4690-B2EF-DE38C941500AQ36004110-CDCBE004-18CD-4D29-855D-1A244890197BQ36396560-43E6C087-EDCE-4E31-8F42-B5C3EB2067A3Q36477271-F234DAED-33C3-4415-9DC7-3598BDE039C2Q36795941-E183ADA4-CD3E-4C4A-923E-D2BAE6765D3EQ37379144-197B3DCE-BA48-424C-BAB5-12ACA4CAC67FQ37608439-23ED3808-8D95-4E5D-B7F8-B3AC911295E6Q37727707-B79C6167-3AA0-4F10-B2EA-168BD70E13BBQ38325289-3252B984-23E6-4B53-B4EE-D30E3D85AC38Q38670410-66188DE4-935F-45EA-8EFA-3CD6DBBF0035Q38697623-4A469A36-FBC5-4C8C-AC46-7190DE10908FQ38701168-52DB1D14-E8B3-4DA6-AE8A-0DF40624E5EFQ39586521-5C8A1192-9C27-4F9A-9945-B73FDD587558Q41747182-9B4F1D71-3095-4EC2-AFE3-EC634848F6C1Q42523219-EC890171-F808-41F3-B455-DE29AEDC9456Q42945449-8010E4F7-608F-46D3-885F-EC54CC4FE93DQ42994509-D2C942D8-1572-4C48-A75D-594866B958CAQ43512312-92B3AA07-E4D8-4057-A9CE-8402F13B9A27
P2860
Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1997
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Hepatic gluconeogenic fluxes a ...... humans. A stable isotope study
@en
Hepatic gluconeogenic fluxes a ...... umans. A stable isotope study.
@nl
type
label
Hepatic gluconeogenic fluxes a ...... humans. A stable isotope study
@en
Hepatic gluconeogenic fluxes a ...... umans. A stable isotope study.
@nl
prefLabel
Hepatic gluconeogenic fluxes a ...... humans. A stable isotope study
@en
Hepatic gluconeogenic fluxes a ...... umans. A stable isotope study.
@nl
P2093
P2860
P356
P1476
Hepatic gluconeogenic fluxes a ...... humans. A stable isotope study
@en
P2093
A Letscher
M Christiansen
M K Hellerstein
P2860
P304
P356
10.1172/JCI119644
P407
P577
1997-09-01T00:00:00Z